Analysts think EDSA stock price could increase by 735%
Apr 07, 2025, 11:25 AM
3.45%
What does EDSA do
Edesa Biotech, headquartered in Markham, Ontario, focuses on developing clinical-stage drugs for inflammatory diseases, including EB05 for ARDS and EB01 for chronic allergic dermatitis. The company employs 16 staff and went public in 2008.
4 analysts think EDSA stock price will increase by 735.34%. The current median analyst target is $19.38 compared to a current stock price of $2.32. The lowest analysts target is $17.17 and the highest analyst target is $22.05.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
